Rational engineering of sdAb-based CAR T cells targeting BCMA enhances antitumor efficacy and persistence in Multiple Myeloma
Vianca Ibarra-Garcia, María Eréndira Calleja-Cervantes, Federica Rochira, Iñigo Azagra-Barber, Patxi San Martín‐Úriz, Paula Aguirre-Ruiz, Saray Rodríguez-Diaz, Rebeca Martínez-Turrillas, Elena Iglesias, Inés Ibáñez-Sala, Eva Molina, Franco Bernasconi-Bisio, Paula Rodríguez-Márquez, Leonor Puchades‐Carrasco, Nuria Gómez-Cebrián, , Felipe Prósper
This study engineers sdAb-based CAR T cells targeting BCMA, showing improved antitumor efficacy and persistence in multiple myeloma compared to existing therapies.
bioRxiv · Jun 5, 2026 · PreprintBioengineering